Preview

Vestnik Moskovskogo universiteta. Seriya 16. Biologiya

Advanced search

EFFECTS OF CHRONICAL INJECTIONS OF CLEBOPRIDE IN LOW DOSES ON BEHAVIOR REACTIONS OF WHITE RATS

https://doi.org/10.1234/XXXX-XXXX-2013-4-3-8

Abstract

Effects of the selective D2-receptors antagonist clebopride on behavior of adult males rats was studied in such tests as sucrose consumption, “open field”, “elevated plus maze” and “complex maze” with a food reinforcement. The drug was injected in small doses (0,2 and 0,4 mg/kg) chronically within two weeks. It was shown that clebopride may have an influence on emotionally-motivational state of experimental animals, on the one hand, causing depressive-like changes, and on the other — improve learning ability and research behavior. A variety of consequences of D2-antagonist action is caused, apparently, by a competition of it’s post- and presynaptic effects.

About the Authors

A. V. Malyshev

Russian Federation


A. M. Zakharov

Russian Federation


K. Yu. Sarkisova
Институт высшей нервной деятельности и нейрофизиологии РАН, лаборатория функциональной биохимии нервной системы, г. Москва
Russian Federation


V. A. Dubynin

Russian Federation


References

1. Byrnes E.M., Ughrin Y., Bruno J.P. Developmental plasticity in the D1- and D2-mediation of motor behavior in rats depleted of dopamine as neonates // Dev. Psychobiol. 1996. Vol. 29. N 8. P. 653—666.

2. D’Haen H., Bossuyt A. Dopamine D2 receptors in depression measured with single photon emission computed tomography // Biol. Psych. 1994. Vol. 35. N 2. P. 128—132.

3. Drago F., Arezzi A., Vitzl A. Effects of acute or chronic administration of substituted benzamides in experimental models of depression in rats // Eur. Neuropsychopharmacol. 2000. Vol. 10. N 6. P. 437—442.

4. D’Aquila P.S., Collu M., Gessa G.L., Serra G. The role of dopamine in the mechanism of action of antidepressant drugs // Eur. J. Pharmacol. 2000. Vol. 405. N 1—3. P. 365—373.

5. Sarkisova K., van Luijtelaar G. The WAG/Rij strain: A genetic animal model of absence epilepsy with comorbidity of depression // Prog. Neuropsychopharmacol. Biol. Psychiatry. 2011. Vol. 35 N 4. P. 854—876.

6. Добрякова Ю.В., Дубынин В.А., Ван Луийтелаар Ж. Материнское поведение крыс линии WAG/Rij в норме и при действии на дофаминергическую систему мозга // Журн. высш. нервн. деят. 2010. Т. 60. № 3. С. 372—380.

7. Саркисова К.Ю., Куликов М.А., Шацкова А.Б. Тревожны ли крысы линии WAG/Rij с генетической absenseэпилепсией? // Журн. высш. нервн. деят. 2005. Т. 55. № 2. С. 241—249.

8. Дубынин В.А., Каменский А.А. Бета-казоморфины и их роль в регуляции поведения. М.: Товарищество научных изданий КМК, 2010. 306 с.

9. Беляева Ю.А., Дубынин В.А., Стоволосов И.С., Добрякова Ю.В., Беспалова Ж.Д., Каменский А.А. Влияние однократного и хронического введения экзорфина С на поведение и обучение детенышей белых крыс // Вестн. Моск. ун-та. Сер. Биология. 2009. № 2. С. 13—18.

10. Benoit-Marand M., Borrelli E., Gonon F. Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo // J. Neurosci. 2001. Vol. 21. N 23. P. 9134—9141.

11. Wasti A., Siddiqui N.A. Alterations in the level of neurotransmitters associated with the chronic treatment of antipsychotic drugs // J. Pak. Med. Assoc. 2010. Vol. 60. N 8. P. 628—632.

12. Lee J., Parish C.L., Tomas D., Horne .K. Chronic cocaine administration reduces striatal dopamine terminal density and striatal dopamine release which leads to drug-seeking behaviour // Neuroscience. 2011. Vol. 174. P. 143—150.


Review

For citations:


Malyshev A.V., Zakharov A.M., Sarkisova K.Yu., Dubynin V.A. EFFECTS OF CHRONICAL INJECTIONS OF CLEBOPRIDE IN LOW DOSES ON BEHAVIOR REACTIONS OF WHITE RATS. Vestnik Moskovskogo universiteta. Seriya 16. Biologiya. 2013;(4):3-8. (In Russ.) https://doi.org/10.1234/XXXX-XXXX-2013-4-3-8

Views: 355


ISSN 0137-0952 (Print)